SCHEMBL6557803

SCHEMBL6557803

O=C(NCCc1ccc(C(=O)Cl)cc1[N+](=O)[O-])OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
IDO1 P14902 1/20 0.47
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
HTT P42858 1/20 0.45
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
PKM P14618 1/20 0.43
ALDH1A1 P00352 2/20 0.43
TAAR1 Q96RJ0 1/20 0.43
KAT2B Q92831 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559025 0.91 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AIDO1LMNA
SCHEMBL19621590 0.85 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AIDO1LMNA
SCHEMBL6557683 0.84 LMNA (0.51) SMN1; SMN2IDO1LMNAL3MBTL1HTT
SCHEMBL6558252 0.83 LMNA (0.50) SMN1; SMN2IDO1LMNAL3MBTL1HTT
SCHEMBL6558086 0.82 POLB (0.52) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL6558232 0.79 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AIDO1LMNA
SCHEMBL6557807 0.77 ATM (0.47) LMNAHTTMAPTALDH1A1
SCHEMBL6557796 0.77 ATM (0.47) LMNAHTTMAPTALDH1A1
SCHEMBL6559976 0.76 LMNA (0.52) SMN1; SMN2IDO1LMNAL3MBTL1HTT
SCHEMBL15156941 0.76 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391454-A1 Substituted benzamide compounds with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2004-02-25 EP disclosed
EP-1195372-A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2002-04-10 EP disclosed
US-6156766-A Benzamide compounds and pharmaceutical use thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-12-05 US disclosed
US-5958944-A TREATMENT OF CIRCULATORY DISEASES IN CORONARY, CEREBRAL, RENAL AND PERIPHERAL ARTERIES, AS A THERAPEUTIC AGENT FOR HYPERTENSION, ANGINA PECTORIS, AND RENAL AND PERIPHERAL CIRCULATION DISORDER, ANTIASTHMATIC AGENT YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-09-28 US disclosed
EP-0757038-A1 BENZAMIDE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-02-05 EP disclosed